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The oryx bacilli are Mycobacterium tuberculosis 
complex organisms for which phylogenetic position and 
host range are unsettled. We characterized 22 isolates by 
molecular methods and propose elevation to subspecies 
status as M. orygis. M. orygis is a causative agent of 
tuberculosis in animals and humans from Africa and South 
Asia.
Traditionally, the Mycobacterium tuberculosis complex comprises tubercle bacilli of 8 distinct subgroups: 
M. tuberculosis, M. africanum, M. canettii, M. bovis, M. 
caprae, M. pinnipedii, M. microti, and M. mungi (1–4). 
Two other distinct branches of the M. tuberculosis complex 
phylogenetic tree exist, the dassie and oryx bacilli, 
causative agents of tuberculosis in the animal species after 
which they are named. Neither has been validly described 
as separate taxa, nor have they been associated with disease 
in humans (1–4).
Oryx bacilli have been isolated from members of the 
Bovidae family, i.e., oryxes, gazelles (3), deer, antelope, 
and waterbucks (5), although their exact host range remains 
unsettled. No human disease caused by the oryx bacilli has 
been reported. These bacilli most likely constitute a separate 
phylogenetic lineage; however, their exact position has not 
been established with valid phylogenetic markers, such as 
large genomic deletions or single nucleotide polymorphisms 
(SNPs). To settle the phylogenetic position and host range 
of the oryx bacilli, we collected all oryx bacillus isolates 
from our laboratory database to establish their sources and 
subjected the isolates to extended phylogenetic analysis.
The Study
We selected 22 isolates on the basis of >90% similarity 
of the IS6110 restriction fragment-length polymorphism 
(RFLP) pattern to that of established and previously 
published oryx bacillus strains; 11 isolates originated from 
animals, and 11 originated from 10 human patients (Figure 
1) (1–3). All isolates yielded smooth to greasy domed 
nonchromogenic colonies in culture (online Technical 
Appendix Figure, wwwnc.cdc.gov/EID/pdfs/11-0888-
Techapp.pdf).
For phylogenetic analysis, we performed SNP and 
region of difference (RD) analysis (2,6). RD and SNP 
typing showed a consistent pattern among the isolates, 
with presence of regions RD1, RD2, RD4, RD5a (Rv2348), 
RD6, and RD13–RD16 and absence of regions RD3, RD5b 
(plcA), and RD7–RD12 (online Technical Appendix Table 
1). The deleted region for RD12 (RD12oryx) was larger than 
that for M. bovis and M. caprae. Analysis of the fl anking 
regions indicated an IS6110 insertion at the M. tuberculosis 
H37Rv coordinates of 3479670 and 3491252 with deletion 
of the intermediate area covering the open reading frames of 
the Rv3111 to Rv3125c genes (online Technical Appendix 
Table 2). Isolates also showed the RDoryx_1, RDoryx_4, 
and RDoryx_wag22 deletions and the mmpL6551AAG 
mutation (online Technical Appendix Table 1). Results 
agreed with those from previous studies (1,6).
Using pncA-1F 5′-GGC CGC GAT GAC ACC TCT-
3′, pncA1-R 5′-GCC GCA GCC AAT TCA GCA GT-3′, 
pncA-2F 5′-CGA AGC GGC GGA CTA CCA TCA CG-3′, 
and pncA-2R 5′-CCC CAC CTG CGG CTG CGA ACC-
3′ primers, we partially sequenced Rv2042c, Rv2044c, and 
the full pncA gene. The pncA sequences of the isolates 
from animals and humans were identical to those of M. 
tuberculosis H37Rv; in codon 38 of the Rv2042c gene, 
directly upstream from pncA, a GTC to GGC (Ser→Ala) 
mutation was noted in all 22 isolates; the partial Rv2042c 
sequence is stored in GenBank (accession no. JF417976). 
To assess the specifi city of the Rv204238 GGC mutation, 
we screened 2 isolates of all M. tuberculosis complex (sub)
species and 2 isolates of all M. tuberculosis groupings, on 
the basis of >60% IS6110 similarity, for this mutation; we 
did not fi nd it in any of the strains tested (data not shown).
We performed spoligotyping and 24-locus myco-
bacterial interspersed repetitive units–variable-number 
tandem repeat (MIRU-VNTR) typing, as described (7,8). 
Spoligotyping mostly showed the sequence type (ST) 587 
pattern in the spolDB4 database and labeled M. africanum 
(9); minor variations in spoligotype were observed (Figure 
1, panel A). All isolates had unique IS6110 RFLP patterns, 
although with >75% similarity; patterns were characterized 
by high (i.e., 17–20) numbers of IS6110 copies (data 
not shown). VNTR typing showed closely related 
patterns (online Appendix Table, wwwnc.cdc.gov/EID/
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DOI: http://dx.doi.org/10.3201/eid1804.110888
article/18/4/11-0888-TA1.htm). A minimum spanning tree 
showed the clonality of the M. orygis isolates (Figure 1, 
panel B). The GenoType MTBC assay (Hain Lifesciences, 
Nehren, Germany) identifi ed all isolates as M. africanum.
Baseline clinical data of humans were extracted from 
the anonymized National Tuberculosis Register. Ethical 
approval was waived for this retrospective laboratory-
based study. Nine of the 10 human patients were of South 
Asian origin; the other was of Southeast Asian origin 
(Figure 1); patients’ average age was 41 years (range: 0–69 
years). Clinically, 6 patients had pulmonary tuberculosis, 3 
had lymphadenitis, and 1 child had tuberculosis diagnosed 
by gastric fl uid culture. All isolates were susceptible to all 
fi rst-line antituberculosis drugs, including pyrazinamide, 
and hence the standard treatment regimen was started for 
all patients. Patients received treatment for an average 
of 9 months; no details about individual regimens were 
available. No bacteriologically proven relapses were noted. 
No information was available about contact-tracing studies.
Conclusions
The oryx bacillus is a phylogenetically distinct lineage 
of the clonal M. tuberculosis complex and thus deserves a 
separate subspecies status; we propose the name M. orygis 
(Latin: oryx, genitive: orygis, of the oryx) to convey that 
this subspecies was fi rst characterized after its isolation 
from an oryx (Figure 2).
The most common spoligotype (ST587) is present in 
the spolDB4 database and labeled M. africanum (9). The 
M. orygis bacteria share the gyrB1450 (G→T) mutation with 
M. africanum, M. microti, and M. pinnipedii (1). Hence, 
the GenoType MTBC assay identifi es M. orygis as M. 
africanum. Thus, M. orygis isolates may have previously 
been misidentifi ed as M. africanum (9,10).
The animal-adapted M. tuberculosis complex lineage 
is thought to have evolved in Africa when an M. africanum–
like clone diverged from M. tuberculosis, as shown by the 
loss of the RD9 locus. Consecutive loss of DNA during the 
adaptation to novel hosts led to the distinct subspecies with 
its distinct host range that we know today (1,4,5,11). This 
matches geographically with the habitats of Oryx species, 
gazelles, and waterbucks.
For M. orygis, the host range remains unknown but may 
include oryxes, waterbucks, and gazelles in eastern Africa 
and the Arabian Peninsula; cows and rhesus monkeys in 
South Asia; and humans. The evolutionary explanation 
for the diversity in geographic distribution and hosts of M. 
orygis remains elusive. This diversity contrasts starkly with 
the conserved VNTR and spoligotype patterns.
The presence of M. orygis in diseased cows and 
a monkey in Bangladesh, unique RFLP patterns, and 
lack of onward transmission suggest animal-to-human 
transmission. As for M. bovis; humans may be accidental, 
dead-end hosts.
M. orygis, unlike M. microti, the dassie bacillus, and 
M. mungi, shows an intact RD1 region. This region encodes 
part of the virulence-related ESX-1 secretion system of 
tubercle bacilli (12).
Molecular characteristics defi ne the isolates previously 
labeled as oryx bacilli as a distinct subspecies in the M. 
tuberculosis complex for which we propose the name M. 
orygis. The Rv204238 GGC mutation is a novel, useful 
genetic marker to identify M. orygis, which is otherwise 
characterized by the presence of genomic regions RD1, 
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Figure 1. Spoligotyping and 24-locus variable number tandem repeat (VNTR) typing results for Mycobacterium orygis. A) Spoligotyping 
patterns for the oryx bacillus isolates in this study; ST587 is the most common pattern (labeled SB0422 at www.mbovis.org), with minor 
deviations. B) Minimum spanning tree based on 24-locus VNTR typing results for the oryx bacillus isolates in this study. One type 
dominates, with few strains representing minor variations. The dominant clone includes isolates from humans and animals. P, pulmonary; 
LN, lymph node; G, gastric juice. Both panels were created by using BioNumerics version 6.1 software (Applied Maths, Sint-Martens-
Latem, Belgium); similarity coeffi cients were calculated by using Dice (spoligotyping) and Pearson (VNTR) methods; cluster analysis was 
done by the UPGMA (unweighted pair group method with arithmetic mean). Isolate 10–1562 (cow, Bangladesh) could not be included in 
(B) because of insuffi cient DNA.
Characterization of M. orygis
RD2, RD4, RD5a (Rv2348), RD6, RD13–RD16, and the 
mmpL6551AAG polymorphism, with absence of regions 
RD3, RD5b (plcA), RD7–RD12, RDoryx_1, RDoryx_4, 
and RDoryx_wag22. The deletion of RD12 is subspecies 
specifi c. Isolates yield the ST587 or closely related 
spoligotypes, 17–20 copies of IS6110, and a distinct 
24-locus VNTR pattern with minor variations. M. orygis 
is a causative agent of tuberculosis in oryxes, gazelles, and 
waterbucks of African origin; cows and rhesus monkeys of 
South Asian origin; and humans.
R.B. and R.S. were supported by the European Community’s 
Seventh Framework Program (FP7/2007-2013) under grant 
agreement no. 201762.
Dr van Ingen is a resident in clinical microbiology at the 
Radboud University Nijmegen Medical Center. His primary 
research interests are the phylogeny and taxonomy of the genus 
Mycobacterium and treatment of tuberculosis and nontuberculous 
mycobacterial disease.
References
  1.  Huard RC, Fabre M, de Haas P, Oliveira Lazzarini LC, van Soolin-
gen D, Cousins D, et al. Novel genetic polymorphisms that further 
delineate the phylogeny of the Mycobacterium tuberculosis com-
plex. J Bacteriol. 2006;188:4271–87. http://dx.doi.org/10.1128/
JB.01783-05
  2.  Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eigl-
meier K, et al. A new evolutionary scenario for the Mycobacterium 
tuberculosis complex. Proc Natl Acad Sci U S A. 2002;99:3684–9. 
http://dx.doi.org/10.1073/pnas.052548299
  3.  van Soolingen D, de Haas PEW, Haagsma J, Eger T, Hermans 
PWM, Ritacco V, et al. Use of various genetic markers in differentia-
tion of Mycobacterium bovis strains from animals and humans and 
for studying epidemiology of bovine tuberculosis. J Clin Microbiol. 
1994;32:2425–33.
  4.  Alexander KA, Laver PN, Michel AL, Williams M, van Helden 
PD, Warren RM, et al. Novel Mycobacterium tuberculosis complex 
pathogen, M. mungi. Emerg Infect Dis. 2010;16:1296–9. http://
dx.doi.org/10.3201/eid1608.100314
  5.  Smith NH, Kremer K, Inwald J, Dale J, Driscoll JR, Gordon SV, et 
al. Ecotypes of the Mycobacterium tuberculosis complex. J Theor 
Biol. 2006;239:220–5. http://dx.doi.org/10.1016/j.jtbi.2005.08.036
  6.  Mostowy S, Inwald J, Gordon S, Martin C, Warren R, Kremer K, 
et al. Revisiting the evolution of Mycobacterium bovis. J Bacte-
riol. 2005;187:6386–95. http://dx.doi.org/10.1128/JB.187.18.6386-
6395.2005
  7.  Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen 
D, Kuijper S, et al. Simultaneous detection and strain differentiation 
of Mycobacterium tuberculosis for diagnosis and epidemiology. J 
Clin Microbiol. 1997;35:907–14.
  8.  Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rüsch-Gerdes 
S, Willery E, et al. Proposal for standardization of optimized myco-
bacterial interspersed repetitive unit–variable-number repeat typing 
of Mycobacterium tuberculosis. J Clin Microbiol. 2006;44:4498–
510. http://dx.doi.org/10.1128/JCM.01392-06
  9.  Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj 
SA, et al. Mycobacterium tuberculosis complex genetic diversity: 
mining the fourth international spoligotyping database (SpolDB4) 
for classifi cation, population genetics and epidemiology. BMC Mi-
crobiol. 2006;6:23. http://dx.doi.org/10.1186/1471-2180-6-23
10.  Rahim Z, Möllers M, te Koppele-Vije A, de Beer J, Zaman K, Matin 
MA, et al. Characterization of Mycobacterium africanum subtype 
I among cows in a dairy farm in Bangladesh using spoligotyping. 
Southeast Asian J Trop Med Public Health. 2007;38:706–13.
11.  Smith NH, Hewinson RG, Kremer K, Brosch R, Gordon SV. Myths 
and misconceptions: the origin and evolution of Mycobacterium 
tuberculosis. Nat Rev Microbiol. 2009;7:537–44. http://dx.doi.
org/10.1038/nrmicro2165
12.  Simeone R, Bottai D, Brosch R. ESX/type VII secretion systems 
and their role in host-pathogen interaction. Curr Opin Microbiol. 
2009;12:4–10. http://dx.doi.org/10.1016/j.mib.2008.11.003
Address for correspondence: Jakko van Ingen, Radboud University 
Nijmegen Medical Center, Department of Clinical Microbiology (574), 
PO Box 9101, 6500HB Nijmegen, the Netherlands; email: j.vaningen@
mmb.umcn.nl
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 18, No. 4, April 2012 655
Figure 2. Updated phylogeny of the Mycobacterium 
tuberculosis complex based on the fi ndings of Brosch 
et al. (2). Combined fi ndings place Mycobacterium 
orygis at a distinct phylogenetic position between 
the M. africanum/dassie bacillus/M. mungi cluster 
and M. microti.
